Natera Inc’s recent filing unveils that its PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon unloaded Company’s shares for reported $0.29 million on Feb 06 ’25. In the deal valued at $177.77 per share,1,632 shares were sold. As a result of this transaction, Moshkevich Solomon now holds 149,768 shares worth roughly $ 25.37 million.
Then, Fesko John sold 663 shares, generating $117,862 in total proceeds. Upon selling the shares at $177.77, the PRESIDENT, CHIEF BUS. OFFICER now owns 156,044 shares.
Before that, Brophy Michael Burkes sold 43,502 shares. Natera Inc shares valued at $7,694,642 were divested by the CHIEF FINANCIAL OFFICER at a price of $176.88 per share. As a result of the transaction, Brophy Michael Burkes now holds 70,629 shares, worth roughly $11.96 million.
Barclays initiated its Natera Inc [NTRA] rating to an Overweight in a research note published on January 23, 2025; the price target was $200. Raymond James revised its rating on February 20, 2024. It rated NTRA as “an Outperform” which previously was an “a Strong buy”.
Price Performance Review of NTRA
On Tuesday, Natera Inc [NASDAQ:NTRA] saw its stock fall -2.31% to $169.38. Over the last five days, the stock has lost -1.63%. Natera Inc shares have risen nearly 7.00% since the year began. Nevertheless, the stocks have risen 143.12% over the past one year. While a 52-week high of $183.00 was reached on 01/13/25, a 52-week low of $68.03 was recorded on 01/21/25. SMA at 50 days reached $168.32, while 200 days put it at $131.65.
Levels Of Support And Resistance For NTRA Stock
The 24-hour chart illustrates a support level at 165.45, which if violated will result in even more drops to 161.52. On the upside, there is a resistance level at 176.86. A further resistance level may holdings at 184.34. The Relative Strength Index (RSI) on the 14-day chart is 48.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.29%. Stochastics %K at 46.81% indicates the stock is a holding.
The most recent change occurred on December 29, 2023 when BTIG Research resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $85.
